In this article, we’ll look at the 10 Best Stocks to Buy and Hold for the Next 6 Months.
Investors are becoming more selective toward tech stocks amid valuation concerns, with the overall market at all-time highs. Amid rotation and valuation concerns, some stocks continue to outperform the overall market. The outperformance comes as investors react to solid earnings results and an improving microenvironment amid lower interest rates.
While valuations in the equity market are high, they are not excessive given the strong corporate earnings. Likewise, economists at Capital Economics expect the overall equity market to rally in 2026 before a potential steep correction sometime next year. The analysts expect the S&P 500 to power through the 8,000 level in 2026 before falling to 7,000 next year, a drop of about 13%.
According to Thomas Mathews, head of markets at Capital Markets, tech stocks could keep on rising.
“We suspect that as the rally progresses, a rise in valuations is more likely than not. Indeed, even though they are, in our view, not yet excessive, it wouldn’t be surprising if investors’ enthusiasm for AI tech were to push valuations to a level perhaps above what might be sustainable in the long run,” Mathews said.
Analysts at Morgan Stanley share similar sentiments, expecting the bull market to continue into the fourth year. The investment bank expects double-digit percentage returns for the S&P 500, with some strategists forecasting even bigger gains. Interest rate cuts, stealth quantitative easing, and a One Big Beautiful Bill are among the tailwinds Morgan Stanley strategists are banking on to keep pushing stocks higher.
“These developments, along with a friendlier regulatory environment for some sectors, have only bolstered investor confidence. However, with expectations so high, the market looks brittle – and even small missteps could cause an outsized reaction,” Morgan Stanley said in a statement.
Source: Pexels
Our Methodology
For this list, we used Finviz screener to select stocks with positive year-to-date gains and that are popular among elite hedge funds in the third quarter of 2025. We then trimmed the list to focus on stocks analysts are bullish on with upside potential of more than 20%. Finally, we ranked the stocks based on their upside potential.
Note: The upside potential data is of February 15.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
Best Stocks to Buy and Hold for the Next 6 Months
10. InterDigital, Inc. (NASDAQ:IDCC)
Stock Upside Potential: 21.61%
Number of Hedge Fund Holders: 35
InterDigital Inc. (NASDAQ:IDCC) is one of the best stocks to buy and hold for the next 6 months. On February 10, InterDigital Inc. (NASDAQ:IDCC) sued Hisense and TCL for allegedly infringing on its intellectual property related to InterDigital’s joint TV licensing program with Sony.
The patents in question relate to HEVC, VP9, and AV1 video compression, as well as high dynamic range (HDR) technologies. The company has initiated legal proceedings before the Munich Local Division of the Unified Patent Court in Germany, the Rio de Janeiro State Court in Brazil, and the Delhi High Court in India.
“Our decades of investment in foundational research have helped change how we watch our favorite movies and shows, and Hisense and TCL cannot be allowed to continue to infringe our IP, particularly while many of their competitors have taken a license,” said Josh Schmidt, Chief Legal Officer, InterDigital.
On February 10, InterDigital inked a strategic collaboration with Razer, a leading global lifestyle brand for gamers. The two are joining forces to establish a center of excellence to enhance the implementation and promotion of haptic technology for improved media experiences.
InterDigital, Inc. (NASDAQ:IDCC) is a prominent research and development company that invents foundational technologies for wireless, video, and AI, licensing these innovations to major mobile device, consumer electronics, and IoT manufacturers. It drives industry standards for 5G, 6G, and video compression.
9. Harmony Gold Mining Company Ltd. (NYSE:HMY)
Stock Upside Potential: 23.87%
Number of Hedge Fund Holders: 23
Harmony Gold Mining Company Ltd (NYSE: HMY) is one of the best stocks to buy and hold for the next 6 months. On February 9, Harmony Gold Mining Company Ltd (NYSE:HMY) confirmed that its newly acquired CSA Copper Mine in Australia requires a capital injection and a strategic rethink.
The company took over the CSA mine in New South Wales last October by acquiring Mac Copper in a deal worth $1.03 billion. The acquisition is part of the company’s push to diversify into copper, as gold mining in South Africa becomes extremely costly due to the depth of the country’s mines.
Under Mac Copper, CSA Copper Mine produced 40,000 metric tons of copper per year. However, it is still unclear if it can maintain or increase the output.
“It could be up to two years or even more potentially to de-risk and de-bottleneck the mine,” Chief Executive Beyers Nel said. “It is a mine that is constrained at the moment. It is a mine that requires a bit of a rethink and recapitalisation.”
Harmony Gold also owns Eva Copper in Queensland, Australia, and is a joint owner with Newmont of Wafi-Golpu, a gold-copper project in Papua New Guinea.
Harmony Gold Mining Company Ltd. (NYSE:HMY) is a major, experienced gold producer and specialist with extensive operations in South Africa and Papua New Guinea, and a growing copper portfolio in Australia. It manages the full mining life cycle, including exploration, development, and operation of underground and surface mines, while being a leader in gold tailings retreatment.
8. BioNTech SE (NASDAQ:BNTX)
Stock Upside Potential: 35.99%
Number of Hedge Fund Holders: 24
BioNTech SE (NASDAQ:BNTX) is one of the best stocks to buy and hold for the next 6 months. On February 2, research firm Leerink Partners downgraded BioNTech SE (NASDAQ:BNTX) to a Market Perform from an Outperform and set a $113 price target.
The downgrade is in response to the stock rallying from its December lows of $92 to $113. The 24% gain over the same period outpaced the 4% gain of the S&P Biotechnology Select Industry. According to Leerink Partners, the new rating and price target bring the stock in line with its discounted cash flow valuation.
Despite the downgrade, the research firm remains confident about BioNTech’s long-term prospects with its oncology strategy. The firm is especially confident about pumitamig, a VEGFA/PD-L1 bispecific antibody partnered with Bristol Myers Squibb. The company remains in a strong financial position with $20.3 billion in cash expected to support the development of the oncology pipeline.
Earlier on January 28, the company’s Supervisory Board appointed Kylie Jimenez to the Management Board as Chief People Officer (“CPO”). The appointment aligns with the company’s push to become a multi-product oncology company by 2030. Jimenez will be responsible for shaping and leading BioNTech’s people strategy and its execution.
On January 21, BioNTech said the FDA gave Fast Track status to its cancer drug BNT113 for HPV16+ head and neck cancer. The decision is based on early trial results, and the drug is being tested with pembrolizumab to improve survival for patients who currently have limited treatment options.
BioNTech SE (NASDAQ:BNTX) is a German biotechnology company that develops immunotherapies and vaccines for cancer, infectious diseases, and other serious conditions.
7. CoreWeave Inc. (NASDAQ:CRWV)
Stock Upside Potential: 37.45%
Number of Hedge Fund Holders: 62
CoreWeave Inc. (NASDAQ:CRWV) is one of the best stocks to buy and hold for the next 6 months. On February 6, CoreWeave Inc. (NASDAQ:CRWV) launched its first big brand campaign called “Ready for Anything, Ready for AI” with Chance the Rapper as the face of it. The campaign shows CoreWeave’s new vision of helping people and companies who are building with AI to go further and innovate faster.
As AI moves from testing to large-scale use, CoreWeave wants to highlight its role as the backbone for AI projects. The campaign explains how its cloud technology is built to handle big ideas and future growth. With recent acquisitions like Weights & Biases, OpenPipe, and Monolith, CoreWeave is uniting everything under one clear brand identity while continuing to grow quickly.
A day earlier on February 5, CoreWeave Inc. unveiled a new solution designed to help organizations validate the performance and costs of artificial intelligence workloads before deployment.
CoreWeave ARENA is a new platform that enables testing applications on production-scale infrastructure. It replaces traditional sandbox environments by providing production-scale compute paired with standardized evaluation tools. The platform also provides access to the company’s Mission Control operating system and AI-native infrastructure through the SUNK and CKS platforms.
Customers are already reporting performance improvements and cost reductions on leveraging CoreWeave ARENA capabilities. One customer experienced a significant reduction in cost of ownership, while another saw 10 times faster training than with cloud services running on GPU hardware.
“Companies are now building products that have to perform in the real world, and quickly. But there’s been a gap between testing a model and actually running it at scale. CoreWeave ARENA closes that gap,” said Chen Goldberg, Senior Vice President of Engineering at CoreWeave.
CoreWeave Inc. (NASDAQ:CRWV) is an AI-focused, specialized cloud computing provider that builds and operates large-scale data centers designed specifically for high-performance GPU-accelerated workloads.
6. Nebius Group N.V. (NASDAQ:NBIS)
Stock Upside Potential: 58.32%
Number of Hedge Fund Holders: 65
Nebius Group N.V. (NASDAQ:NBIS) is one of the best stocks to buy and hold for the next 6 months. On February 10, Nebius Group NV (NASDAQ:NBIS) reached an agreement to acquire Tavily. With the acquisition, the company gains access to a company that develops software to help artificial intelligence agents search for up-to-date information needed for financial trading and coding.
According to people familiar with the matter, Nebius is to pay $275 million as part of the deal, which will also see Tavily founder and CEO Rotem Weiss join the company. The acquisition will strengthen the company’s efforts to offer software for handling AI workloads while also providing access to open-source models.
Additionally, the acquisition will advance Nebius’ strategy of building a unified platform that enables vertical AI companies and enterprises to build, tune, and run autonomous agents. By leveraging Tavily’s agentic search solution, Nebius will also expand its integrated software stack that developers need to assemble and operate enterprise-grade agentic systems.
“This acquisition brings the search layer directly into our stack, so developers can focus on their applications instead of managing multiple vendors. Our strategy is clear: provide an open platform that serves everyone from startups to the largest enterprises, giving them the tools to own their AI destiny,” Roman Chernin, co-founder and Chief Business Officer of Nebius, said:
Nebius Group N.V. (NASDAQ:NBIS) is focused on building full-stack infrastructure for the artificial intelligence (AI) industry. It provides AI-native cloud computing, large-scale GPU clusters, and developer tools for training and running AI models.
5. Cipher Mining Inc. (NASDAQ:CIFR)
Stock Upside Potential: 65.70%
Number of Hedge Fund Holders: 40
Cipher Mining Inc. (NASDAQ:CIFR) is one of the best stocks to buy and hold for the next 6 months. On February 9, Morgan Stanley initiated coverage of Cipher Mining Inc. (NASDAQ:CIFR) with an Overweight rating and a $38 price target.
According to the investment bank, Cipher Mining is one of the Bitcoin mining companies well-positioned to benefit from a pivot to data centers. The investment bank expects Bitcoin companies with established data centers to naturally attract infrastructure investors who value long-term, stable cash flows. Consequently, Morgan Stanley compares Cipher Mining’s business model to data center REITs that trade at 20X EV/FY1 EBITDA.
Meanwhile, on February 4, the company’s wholly owned subsidiary, Black Perl Compute LLC, completed a $2 billion 6.125% senior secured note due 2031. The unit is to use net proceeds from the offering to finance the construction costs of the Black Pearl Facility, a high-performance computing data center in Texas. It will also use $232.5 million to reimburse Cipher Mining for its prior equity contribution.
Cipher Mining Inc. (NASDAQ:CIFR) constructs and operates industrial-scale data centers in the U.S. for Bitcoin mining, while rapidly pivoting to become a major developer of high-performance computing (HPC) infrastructure for Artificial Intelligence (AI). The company, which is pivoting to hybrid operations, generates revenue from mining and long-term hosting deals.
4. Iren Limited (NASDAQ:IREN)
Stock Upside Potential: 83.87%
Number of Hedge Fund Holders: 52
IREN Ltd (NASDAQ:IREN) is one of the best stocks to buy and hold for the next 6 months. On February 6, analysts at Compass Point reiterated a Buy rating on IREN Ltd (NASDAQ:IREN) and settled on a $105 price target.
The positive stance follows the company expanding its secured power base to 4.5GW of grid-connected power with the addition of 1.6GW from the Oklahoma campus. The company is increasingly advancing deployments in Canada and Texas.
Amid the expansion drive, on February 6, research firm Citizens reiterated a Market Outperform rating on IREN Ltd and an $80 price target.
Citizens have expressed confidence in IREN Ltd’s long-term prospects amid a strategic pivot from Bitcoin mining to providing higher-quality data center capacity to large-scale customers. The company already has over 2 gigawatts of capacity available to pursue contracts with hyperscalers.
In addition, IREN has secured a $3.6 billion in GPU financing for its Microsoft contract on February 5. The financing will supplement Microsoft’s $1.9 billion prepayment, thereby allowing the company to cover 95% of GPU-related capital expenditures for its targeted 140,000-GPU expansion. The expansion drive is expected to deliver $3.4 billion in annual recurring revenue.
Iren Limited (NASDAQ:IREN) operates data centers powered by renewable energy, specializing in high-performance computing for artificial intelligence (AI) cloud services and Bitcoin mining. The company recently shifted focus to AI infrastructure, securing major deals, including a $9.7 billion partnership with Microsoft.
3. Praxis Precision Medicines, Inc. (NASDAQ:PRAX)
Stock Upside Potential: 90.85%
Number of Hedge Fund Holders: 33
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is one of the best stocks to buy and hold for the next 6 months. On February 10, Guggenheim raised its price target for Praxis Precision Medicines Inc. (NASDAQ:PRAX) to $800 from $760 while reiterating a Buy rating.
The research firm raised its price target, impressed by the significant market opportunity for ulixacaltamide, the company’s flagship treatment for essential tremor (ET). According to Guggenheim, Praxis Precision is well-positioned to capitalize on one of the largest and underpenetrated markets in neurology. The essential tremor market is valued at over $15 billion, and Praxis Precision is poised to achieve peak sales of $5- $10 billion with ulixacaltamide.
Earlier on January 28, Piper Sandler raised the stock’s price target to $1200 from $450 while maintaining an Overweight rating. The significant price target hike is in response to ulixacaltamide’s significant success in essential tremor. In addition, the research firm has touted progress in relutrigine and epileptic encephalopathies (DEEs). The research firm expects the company to achieve more than $20 billion in revenue with less than 5% peak market share.
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into therapies for CNS disorders characterized by an imbalance between neuronal excitation and inhibition.
2. Aurora Innovation, Inc. (NASDAQ:AUR)
Stock Upside Potential: 90.89%
Number of Hedge Fund Holders: 39
Aurora Innovation Inc. (NASDAQ:AUR) is one of the best stocks to buy and hold for the next 6 months. On February 12, Cantor Fitzgerald reaffirmed its Overweight rating and $12 price target on Aurora Innovation (NASDAQ:AUR), citing strong progress in autonomous trucking.
The firm noted Aurora’s 4.5 million autonomous miles, including 250,000 driverless miles since April, positioning the company as a leader in self-driving trucks despite generating only $2 million in revenue over the past year. Cantor also pointed to Aurora’s partnership with Continental, which is expected to scale hardware production beginning in 2027 and serve as a key growth catalyst.
Just a day earlier, Aurora expanded its operations to 10 autonomous trucking routes and announced plans to deploy 200 driverless trucks by the end of 2026. The company already runs a 1,000‑mile driverless route between Phoenix and Fort Worth that exceeds federal hours‑of‑service limits, demonstrating the advanced capabilities of its Aurora Driver system.
Aurora has completed 250,000 driverless miles with zero collisions and continues to enhance its technology, including a fourth software update that enables safe operations in challenging weather such as rain, fog, and heavy wind. Together, these milestones highlight Aurora’s growing scale, improving safety record, and long‑term potential in autonomous freight.
Aurora Innovation is also launching a next-generation hardware kit for International LT Series trucks. It is also on course to achieve positive free cash flow by 2028. On February 11, the company delivered fourth-quarter results, reporting a loss of $0.110 a share, better than the $0.12 a share expected. Revenue in the quarter totaled $1 million, missing estimates of $1.69 million.
Aurora Innovation, Inc. (NASDAQ:AUR) develops an autonomous driving system designed to enable fully driverless operation for commercial trucks and passenger vehicles. It also operates a commercial, driverless freight service in Texas, partnering with carriers to move goods more efficiently.
1. Vaxcyte Inc. (NASDAQ:PCVX)
Stock Upside Potential: 121.95%
Number of Hedge Fund Holders: 46
Vaxcyte Inc. (NASDAQ:PCVX) is one of the best stocks to buy and hold for the next 6 months. On February 11, Vaxcyte Inc. (NASDAQ:PCVX) confirmed the dosing of the first participants in its OPUS-3 Phase 3 trial. The trial is evaluating the VAX-31 pneumococcal conjugate vaccine in adults who previously received pneumococcal vaccination.
VAX-31 is a candidate 31-valent pneumococcal conjugate vaccine designed to cover approximately 95% of invasive pneumococcal disease. The biotechnology company plans to enroll 720 healthy US adults aged 50 and older who have previously received pneumococcal vaccination into the trial.
The company is optimistic about topline data from the OPUS-3 and OPUS-2 trials in the first half of 2027. The US Food and Drug Administration has already granted VAX-31 Breakthrough Therapy designation for the use of the vaccine in pneumococcal disease and pneumonia caused by Streptococcus pneumoniae.
Earlier on February 2, Vaxcyte closed a $632.5 million public offering following the sale of 12.65 million shares. The new capital injection positions the company in a solid financial position to advance the development of VAX-31, a 31-valent pneumococcal conjugate vaccine.
Vaxcyte Inc. (NASDAQ:PCVX) is a clinical-stage biotechnology company developing engineered, high-fidelity vaccines to treat and prevent bacterial infections. Using a proprietary cell-free protein synthesis platform, it develops vaccines targeting complex, hard-to-treat diseases, with a primary focus on pneumococcal conjugate vaccines (PCVs) for adults and infants.
While we acknowledge the potential of PCVX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PCVX and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 11 Best High Return Penny Stocks to Buy Right Now and 10 High-Growth Low PE Stocks to Buy Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
